DHEA (Dehydroepiandrosterone) Research Overview (also known as Dehydroepiandrosterone, DHEA-S, Prasterone, Fidelin, Intrarosa, Dehydroisoandrosterone)

At a glance

DHEA is a naturally occurring steroid hormone produced mainly in the adrenal cortex from cholesterol. It is a precursor that tissues can convert into androgens and estrogens, rather than another form of testosterone. Research discussed here examines adrenal insufficiency, age-related hormonal changes, mood and sexual-health outcomes.

What Is DHEA (Dehydroepiandrosterone)?

Dehydroepiandrosterone, commonly abbreviated DHEA, is an endogenous C19 steroid hormone and a major intermediate in human steroidogenesis. It is synthesized mainly in the zona reticularis of the adrenal cortex from cholesterol, although smaller amounts are produced in the gonads, skin, and nervous system. Adrenal cholesterol is converted through pregnenolone and 17-hydroxypregnenolone to DHEA by the enzymes CYP11A1, CYP17A1, and related hydroxysteroid dehydrogenases. DHEA is often described as an androgen precursor because peripheral tissues can convert it to androstenedione, testosterone, dihydrotestosterone, estrone, and estradiol. It is not, however, simply a circulating form of testosterone: its biological effects vary with tissue-specific enzymes, receptor expression, age, sex, and local conversion pathways.

DHEA secretion rises during adrenarche, increases through adolescence, and generally reaches its highest circulating concentration during the second or third decade of life. Thereafter, levels decline progressively, often reaching approximately 10-20% of young-adult concentrations by the seventh or eighth decade. This age-associated fall is sometimes called adrenopause, although it is not a universally accepted clinical diagnosis and does not necessarily represent a disease state. Most circulating DHEA is rapidly sulfated by steroid sulfotransferase to form DHEA sulfate, or DHEA-S. DHEA-S is generally present at concentrations roughly tenfold higher than free DHEA and has a substantially longer half-life, making it a more stable clinical marker of adrenal androgen production. DHEA can also be synthesized locally in the brain, where it and DHEA-S act as neurosteroids. Research on DHEA expanded notably during the 1980s and 1990s as investigators explored aging, immune function, mood, and sexual physiology. The 2000s brought larger randomized trials and more critical reviews, and contemporary work focuses on carefully defined deficiencies, vaginal prasterone, tissue-specific actions, and the distinction between biochemical associations and clinically meaningful benefits.

Quick Reference

Member reference tables summarize the compound's research parameters.

Sign in to view this section

Research Indications

Adrenal Insufficiency Replacement
Supported Research

Well-being and fatigue

Randomized studies in people with primary or secondary adrenal insufficiency have reported modest improvements in well-being, fatigue, or mood with DHEA replacement, although effects are variable.

Female sexual function

In women with adrenal insufficiency, physiologic DHEA replacement has shown benefits for libido and sexual interest in some trials; androgenic adverse effects can limit use.

Age-Related Hormonal Decline
Preliminary Data

Body composition and physical function

DHEA levels decline with age, but controlled trials in healthy older adults have generally found little or no clinically meaningful improvement in muscle strength, physical performance, or body composition.

Bone and metabolic markers

Some studies suggest small changes in bone turnover, bone density, or insulin sensitivity in selected populations, but findings are inconsistent and not sufficient to establish an anti-aging indication.

Mood and Depressive Symptoms
Emerging Evidence

Adjunctive depression research

Small clinical trials and meta-analyses have suggested possible antidepressant effects, particularly in midlife populations, but study size, duration, and dosing heterogeneity limit certainty.

Cognitive outcomes

Evidence does not reliably support DHEA for cognition or dementia prevention. Neuroactive steroid mechanisms remain an active research area rather than an established use.

Sexual Health in Midlife
Emerging Evidence

Postmenopausal symptoms

Oral DHEA has not consistently improved menopausal symptoms or sexual function in otherwise healthy postmenopausal women; local vaginal DHEA is a distinct treatment with different exposure and evidence.

Androgen precursor activity

DHEA can convert peripherally to androgens and estrogens. Resulting hormonal effects differ substantially by sex, age, tissue enzyme activity, and baseline endocrine status.

Research Protocols

As reported in cited literature and research-community logs (see Research Citations below), not a personal dosing recommendation.

This member section describes parameters reported in the research literature.

Sign in to view this section

Peptide Interactions

This member section summarizes reported compound interactions and evidence limitations.

Sign in to view this section

Reported Research Time Points

This member section summarizes reported research time points.

Sign in to view this section

Safety Notes

Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.

This member section discusses research safety considerations and uncertainties.

Sign in to view this section

Quality Indicators

Verified Marker

Lot-specific certificate of analysis

The listed research text specifies choosing a product with a batch or lot-specific COA that identifies the tested material, reports assay results, and is accessible before purchase.

Verified Marker

Independent identity and purity testing

Prefer transparent third-party testing using an appropriate analytical method, such as HPLC or LC-MS, with stated DHEA identity and purity results.

Verified Marker

Heavy-metal and microbiological screening

Quality documentation should include screening for heavy metals and, for finished capsules, relevant microbiological contaminants.

Acceptable Range

Clear capsule strength and excipient disclosure

The label should state DHEA amount per capsule, serving size, inactive ingredients, lot number, expiry date, and manufacturer contact information.

Quality Concern

Proprietary blends or unverifiable testing claims

The listed research text specifies avoiding products that obscure the DHEA dose, provide only generic certificates, lack a lot number, or claim pharmaceutical equivalence without verifiable documentation.

Research Citations

Research Focus

adrenal hormone, androgen precursor, estrogen precursor, anti-aging, adrenopause, testosterone, body composition, cognitive function, immune modulation, mood, sexual function

Related Compounds

Browse all peptides in the Encyclopedia →